RJA
CRI icon

Raymond James & Associates’s Carter's CRI Stock Holding History

Raymond James & Associates’s Portfolio CRI Stock Details CRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$6.45M Sell
99,278
-7,912
-7% -$508K ﹤0.01% 1477
2024
Q2 		$6.64M Buy
107,190
+21,358
+25% +$1.48M ﹤0.01% 1395
2024
Q1 		$7.27M Buy
85,832
+31,511
+58% +$2.5M ﹤0.01% 1335
2023
Q4 		$4.07M Buy
54,321
+1,463
+3% +$102K ﹤0.01% 1668
2023
Q3 		$3.66M Buy
52,858
+294
+0.6% +$21K ﹤0.01% 1656
2023
Q2 		$3.82M Sell
52,564
-11,553
-18% -$781K ﹤0.01% 1657
2023
Q1 		$4.61M Buy
64,117
+615
+1% +$47.1K ﹤0.01% 1511
2022
Q4 		$4.74M Buy
63,502
+5,426
+9% +$389K ﹤0.01% 1438
2022
Q3 		$3.81M Buy
58,076
+9,989
+21% +$765K ﹤0.01% 1566
2022
Q2 		$3.39M Buy
48,087
+20,852
+77% +$1.68M ﹤0.01% 1666
2022
Q1 		$2.5M Buy
27,235
+6,241
+30% +$586K ﹤0.01% 1973
2021
Q4 		$2.13M Buy
20,994
+264
+1% +$26.9K ﹤0.01% 2134
2021
Q3 		$2.02M Sell
20,730
-171
-0.8% -$17.3K ﹤0.01% 2098
2021
Q2 		$2.16M Sell
20,901
-261
-1% -$26.6K ﹤0.01% 2046
2021
Q1 		$1.88M Sell
21,162
-1,384
-6% -$128K ﹤0.01% 2068
2020
Q4 		$2.12M Sell
22,546
-840
-4% -$73.9K ﹤0.01% 1858
2020
Q3 		$2.02M Sell
23,386
-1,866
-7% -$155K ﹤0.01% 1761
2020
Q2 		$2.04M Buy
25,252
+1,667
+7% +$133K ﹤0.01% 1717
2020
Q1 		$1.55M Buy
23,585
+3,827
+19% +$368K ﹤0.01% 1720
2019
Q4 		$2.16M Buy
19,758
+1,254
+7% +$127K ﹤0.01% 1776
2019
Q3 		$1.69M Buy
18,504
+454
+3% +$41.4K ﹤0.01% 1879
2019
Q2 		$1.76M Sell
18,050
-299
-2% -$29.1K ﹤0.01% 1873
2019
Q1 		$1.85M Sell
18,349
-5,513
-23% -$492K ﹤0.01% 1812
2018
Q4 		$1.95M Buy
23,862
+5,047
+27% +$459K ﹤0.01% 1679
2018
Q3 		$1.85M Buy
18,815
+4,002
+27% +$423K ﹤0.01% 1858
2018
Q2 		$1.61M Buy
14,813
+345
+2% +$37.1K ﹤0.01% 1907
2018
Q1 		$1.51M Buy
14,468
+283
+2% +$32.9K ﹤0.01% 1866
2017
Q4 		$1.67M Buy
14,185
+11,190
+374% +$1.16M ﹤0.01% 1803
2017
Q3 		$296K Sell
2,995
-24,114
-89% -$2.15M ﹤0.01% 2801
2017
Q2 		$2.41M Sell
27,109
-94
-0.3% -$8.27K 0.01% 1444
2017
Q1 		$2.44M Buy
+27,203
New +$2.34M 0.01% 1409

Other funds holding CRI

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Raymond James & Associates's CRI Position: Q3 2024 in Review

Raymond James & Associates reduced its Carter's (CRI) stake by 7.4% in Q3 2024, selling an estimated $508K and leaving 99,278 shares worth $6.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Raymond James & Associates first reported a position in CRI in Q1 2017 and has held it in 31 quarters since. The position peaked at $7.27M in Q1 2024. 329 funds tracked by Wall St. Rank hold CRI as of Q3 2024.

  • Raymond James & Associates held 99,278 shares of Carter's worth $6.45M as of Q3 2024.
  • Raymond James & Associates sold 7,912 Carter's shares in Q3 2024, an estimated $508K.
  • Carter's made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1477 holding.
  • Raymond James & Associates first reported a position in Carter's in Q1 2017 and has held it in 31 quarters since.
  • Raymond James & Associates's Carter's position peaked at $7.27M in Q1 2024.
  • 329 funds tracked by Wall St. Rank held Carter's as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.